BASF and Biomillenia today announced the signing of a microbiome discovery agreement. The collaboration aims to identify novel dermocosmetic active ingredients involved in promoting skin health. The French company Biomillenia will contribute its unique microbiome-on-a-chip […]
4D pharma plc (AIM: DDDD), a pharmaceutical company leading the development of Live Biotherapeutics, today announces that the Company has entered into a research collaboration and option to license agreement with MSD, the tradename of […]
Researchers at Western University have developed a new way to deliver the DNA-editing tool CRISPR-Cas9 into microorganisms in the lab, providing a way to efficiently launch a targeted attack on specific bacteria. Published in Nature […]
Aspirin is one of the oldest drugs, widely used for pain relief, suppression of inflammation and prevention of heart disease and stroke. However, well known to many patients is a troublesome side effect of intestinal […]
Biomica, an emerging biopharmaceutical company developing innovative microbiome-based therapeutics, and a subsidiary of Evogene Ltd. (NASDAQ: EVGN) and (TASE: EVGN), announces the initiation of pre-clinical studies for BMC321 & BMC322, two rationally-designed microbial consortia aimed […]
Evolve BioSystems and the Regents of the University of California have jointly filed and served a patent infringement complaint against Abbott Laboratories. The complaint regards Abbott’s soon-to-be-launched product Similac Probiotic Tri-Blend. Evolve BioSystems was founded […]
Scientists have discovered that soil microbes can make plants more resistant to an aggressive disease – opening new possibilities for sustainable food production. Bacterial wilt disease caused by Ralstonia solanacearum infects several plants including tomatoes […]
A new 10-year agreement enables Chr. Hansen Denmark to switch 100% to green power from two brand new solar parks. The agreement underlines Chr. Hansen’s commitment to a sustainable future and will create more green […]
Vedanta Biosciences, a clinical-stage company developing a new category of therapies for immune-mediated diseases based on rationally-defined consortia of human microbiome-derived bacteria, today announced a $16.6 million Series C-2 financing round, bringing the total capital […]
Babies born vaginally have different gut bacteria – their microbiome – than those delivered by Caesarean, research has shown. Scientists from the Wellcome Sanger Institute, UCL, the University of Birmingham and their collaborators discovered that […]
All living organisms exist and function only in cooperation with an abundance of symbiotic microorganisms, and have developed together with them over the course of the earth’s history. This central finding of modern life sciences […]